Edwards Lifesciences
964 hedge funds and large institutions have $37.9B invested in Edwards Lifesciences in 2019 Q3 according to their latest regulatory filings, with 118 funds opening new positions, 314 increasing their positions, 354 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 921 → 964 (+43)
0.57% less ownership
Funds ownership: 249.45% → 248.88% (-0.57%)
11% less repeat investments, than reductions
Existing positions increased: 314 | Existing positions reduced: 354
Holders
964
Holding in Top 10
30
Calls
$380M
Puts
$289M
Top Buyers
| 1 | +$214M | |
| 2 | +$149M | |
| 3 | +$124M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$101M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$99.2M |
Top Sellers
| 1 | -$131M | |
| 2 | -$118M | |
| 3 | -$92M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$80.9M |
| 5 |
DGI
Disciplined Growth Investors
Minneapolis,
Minnesota
|
-$75.8M |